Open AccessMinocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients
Author(s) -
Caroline A. Arout,
Andrew J. Waters,
R. Ross MacLean,
Peggy Compton,
Mehmet Sofuoglu
Publication year - 2018
Publication title -
psychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.378
H-Index - 196
eISSN - 1432-2072
pISSN - 0033-3158
DOI - 10.1007/s00213-018-5146-7
Subject(s) - minocycline , affect (linguistics) , addiction , opioid , opioid addiction , medicine , psychology , psychiatry , pharmacology , clinical psychology , chemistry , receptor , antibiotics , biochemistry , communication
Minocycline, a tetracycline antibiotic, inhibits activation of microglia. In preclinical studies, minocycline prevented development of opioid tolerance and opioid-induced hyperalgesia (OIH). The goal of this study was to determine if minocycline changes pain threshold and tolerance in individuals with opioid use disorder who are maintained on agonist treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom